142 related articles for article (PubMed ID: 37948295)
1. Virtual screening, pharmacokinetics & MD simulation study of active phytoconstituents of
Deshpande N S; Dwivedi PSR; Revanasiddappa BC
J Biomol Struct Dyn; 2023 Nov; ():1-17. PubMed ID: 37948295
[No Abstract] [Full Text] [Related]
2. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
[TBL] [Abstract][Full Text] [Related]
3. Computational investigation of phytochemicals from
Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
[TBL] [Abstract][Full Text] [Related]
4. In silico and in vitro analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat.
Mandal SK; Kumar BK; Sharma PK; Murugesan S; Deepa PR
Comput Biol Med; 2022 Aug; 147():105796. PubMed ID: 35809408
[TBL] [Abstract][Full Text] [Related]
5. Identification of some bioactive compounds from Trignonella foenumgraecum as possible inhibitors of PPARϒ for diabetes treatment through molecular docking studies, pharmacophore modelling and ADMET profiling: An in-silico study.
Okoh OS; Yakubu A; Adegboyega AE; Uti DE; Obeten UN; Agada SA; Oluwaloni F; Johnson GI; Mela LP; Asomadu RO; Iwaloye O; Johnson TO; Orji OU
PLoS One; 2023; 18(5):e0284210. PubMed ID: 37200359
[TBL] [Abstract][Full Text] [Related]
6. Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule checkmate to cancer therapy.
Lokhande KB; Ballav S; Thosar N; Swamy KV; Basu S
J Mol Model; 2020 Aug; 26(9):242. PubMed ID: 32816149
[TBL] [Abstract][Full Text] [Related]
7.
Pattnaik S; Murmu S; Prasad Rath B; Singh MK; Kumar S; Mohanty C
J Biomol Struct Dyn; 2024 Jan; ():1-29. PubMed ID: 38287503
[TBL] [Abstract][Full Text] [Related]
8. In silico analysis of phytoconstituents from
Mandar BK; Khanal P; Patil BM; Dey YN; Pasha I
In Silico Pharmacol; 2021; 9(1):3. PubMed ID: 33442530
[TBL] [Abstract][Full Text] [Related]
9. In silico identification of potential drug compound against Peroxisome proliferator-activated receptor-gamma by virtual screening and toxicity studies for the treatment of Diabetic Nephropathy.
Singh S; Mohanty A
J Biomol Struct Dyn; 2018 May; 36(7):1776-1787. PubMed ID: 28539091
[TBL] [Abstract][Full Text] [Related]
10. Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer.
Ballav S; Lokhande KB; Yadav RS; Ghosh P; Swamy KV; Basu S
Mol Divers; 2023 Dec; 27(6):2867-2885. PubMed ID: 36544031
[TBL] [Abstract][Full Text] [Related]
11. Discovery of New Dual-Target Agents Against PPAR-γ and α-Glucosidase Enzymes with Molecular Modeling Methods: Molecular Docking, Molecular Dynamic Simulations, and MM/PBSA Analysis.
Kaya S; Tatar-Yılmaz G; Aktar BSK; Emre EEO
Protein J; 2024 Apr; ():. PubMed ID: 38642318
[TBL] [Abstract][Full Text] [Related]
12. Citrus nutraceutical eriocitrin and its metabolites are partial agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a molecular docking and molecular dynamics study.
Gangadhariah M; Pardhi T; Ravilla J; Chandra S; Singh SA
J Biomol Struct Dyn; 2023; 41(21):11373-11393. PubMed ID: 36576222
[TBL] [Abstract][Full Text] [Related]
13. Identification of phytochemicals as putative ligands for the targeted modulation of peroxisome proliferator-activated receptor α (PPARα) in animals.
Hassan FU; Rehman MS; Javed M; Ahmad K; Fatima I; Safdar M; Ashraf N; Nadeem A
J Biomol Struct Dyn; 2023 Oct; ():1-12. PubMed ID: 37837423
[TBL] [Abstract][Full Text] [Related]
14.
Feng XY; Ding TT; Liu YY; Xu WR; Cheng XC
J Biomol Struct Dyn; 2021 Mar; 39(5):1853-1864. PubMed ID: 32189570
[TBL] [Abstract][Full Text] [Related]
15. Uncovering PPAR-γ agonists: An integrated computational approach driven by machine learning.
Haider S; Shafiq M; Siddiqui AR; Sardar M; Mushtaq M; Shafeeq S; Nur-E-Alam M; Ahmad A; Ul-Haq Z
J Mol Graph Model; 2024 Jun; 129():108742. PubMed ID: 38422823
[TBL] [Abstract][Full Text] [Related]
16. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
17. Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors -α/γ dual agonists for treatment of metabolic disorders.
Nath V; Agrawal R; Kumar V
J Biomol Struct Dyn; 2020 Feb; 38(2):511-523. PubMed ID: 30767625
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of new 1,2,4-oxadiazole based trans- acrylic acid derivatives as potential PPAR-alpha/gamma dual agonist.
Kaur P; Bhat ZR; Bhat S; Kumar R; Kumar R; Tikoo K; Gupta J; Khurana N; Kaur J; Khatik GL
Bioorg Chem; 2020 Jul; 100():103867. PubMed ID: 32353564
[TBL] [Abstract][Full Text] [Related]
19. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach.
Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A
J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973
[TBL] [Abstract][Full Text] [Related]
20.
Raman APS; Pongpaiboon S; Bhatia R; Lal Dabodhia K; Kumar A; Kumar D; Jain P; Sagar M; Singh P; Kumari K
J Biomol Struct Dyn; 2023 Aug; ():1-17. PubMed ID: 37545143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
